nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—HTR2C—bipolar disorder	0.814	1	CbGaD
Metixene—HTR2C—telencephalic ventricle—bipolar disorder	0.00168	0.338	CbGeAlD
Metixene—Diphenylpyraline—SLC6A3—bipolar disorder	0.000495	0.0411	CrCbGaD
Metixene—CHRM4—nervous system—bipolar disorder	0.000461	0.0926	CbGeAlD
Metixene—Quetiapine—DRD5—bipolar disorder	0.000447	0.0371	CrCbGaD
Metixene—Protriptyline—SLC6A4—bipolar disorder	0.000412	0.0342	CrCbGaD
Metixene—Mirtazapine—DRD4—bipolar disorder	0.000401	0.0333	CrCbGaD
Metixene—CHRM5—nervous system—bipolar disorder	0.00036	0.0724	CbGeAlD
Metixene—CHRM4—brain—bipolar disorder	0.000352	0.0708	CbGeAlD
Metixene—Maprotiline—SLC6A3—bipolar disorder	0.000352	0.0292	CrCbGaD
Metixene—Mirtazapine—DRD3—bipolar disorder	0.000346	0.0287	CrCbGaD
Metixene—Mirtazapine—SLC6A3—bipolar disorder	0.000322	0.0267	CrCbGaD
Metixene—Maprotiline—HTR2C—bipolar disorder	0.000318	0.0264	CrCbGaD
Metixene—Mirtazapine—HTR2C—bipolar disorder	0.00029	0.0241	CrCbGaD
Metixene—Mesoridazine—DRD3—bipolar disorder	0.00029	0.0241	CrCbGaD
Metixene—Mirtazapine—HTR1A—bipolar disorder	0.000282	0.0234	CrCbGaD
Metixene—Cyproheptadine—HTR2C—bipolar disorder	0.000282	0.0234	CrCbGaD
Metixene—Prochlorperazine—DRD3—bipolar disorder	0.000281	0.0233	CrCbGaD
Metixene—CHRM5—brain—bipolar disorder	0.000275	0.0553	CbGeAlD
Metixene—Cyproheptadine—HTR1A—bipolar disorder	0.000273	0.0227	CrCbGaD
Metixene—Maprotiline—DRD2—bipolar disorder	0.000262	0.0217	CrCbGaD
Metixene—Mianserin—DRD3—bipolar disorder	0.000254	0.0211	CrCbGaD
Metixene—CHRM2—nervous system—bipolar disorder	0.000247	0.0497	CbGeAlD
Metixene—Mesoridazine—HTR2C—bipolar disorder	0.000244	0.0202	CrCbGaD
Metixene—Mirtazapine—SLC6A4—bipolar disorder	0.000241	0.02	CrCbGaD
Metixene—CHRM3—thyroid gland—bipolar disorder	0.000239	0.0481	CbGeAlD
Metixene—Mirtazapine—DRD2—bipolar disorder	0.000239	0.0199	CrCbGaD
Metixene—HTR2C—nervous system—bipolar disorder	0.000238	0.0479	CbGeAlD
Metixene—Mesoridazine—HTR1A—bipolar disorder	0.000237	0.0196	CrCbGaD
Metixene—Mianserin—SLC6A3—bipolar disorder	0.000237	0.0196	CrCbGaD
Metixene—Prochlorperazine—HTR2C—bipolar disorder	0.000236	0.0196	CrCbGaD
Metixene—Cyproheptadine—DRD2—bipolar disorder	0.000232	0.0193	CrCbGaD
Metixene—Quetiapine—DRD4—bipolar disorder	0.000229	0.019	CrCbGaD
Metixene—CHRM1—nervous system—bipolar disorder	0.000225	0.0452	CbGeAlD
Metixene—Thioridazine—DRD1—bipolar disorder	0.000215	0.0178	CrCbGaD
Metixene—Mianserin—HTR2C—bipolar disorder	0.000213	0.0177	CrCbGaD
Metixene—Promazine—DRD4—bipolar disorder	0.00021	0.0174	CrCbGaD
Metixene—Mianserin—HTR1A—bipolar disorder	0.000207	0.0172	CrCbGaD
Metixene—Maprotiline—HTR2A—bipolar disorder	0.000202	0.0168	CrCbGaD
Metixene—CHRM3—nervous system—bipolar disorder	0.000201	0.0405	CbGeAlD
Metixene—Mesoridazine—DRD2—bipolar disorder	0.000201	0.0167	CrCbGaD
Metixene—Quetiapine—DRD3—bipolar disorder	0.000197	0.0164	CrCbGaD
Metixene—Prochlorperazine—DRD2—bipolar disorder	0.000194	0.0161	CrCbGaD
Metixene—Quetiapine—DRD1—bipolar disorder	0.000193	0.0161	CrCbGaD
Metixene—CHRM2—brain—bipolar disorder	0.000189	0.038	CbGeAlD
Metixene—Mirtazapine—HTR2A—bipolar disorder	0.000185	0.0153	CrCbGaD
Metixene—Thioridazine—HTR2C—bipolar disorder	0.000184	0.0153	CrCbGaD
Metixene—HTR2C—brain—bipolar disorder	0.000182	0.0366	CbGeAlD
Metixene—Cyproheptadine—HTR2A—bipolar disorder	0.000179	0.0149	CrCbGaD
Metixene—Thioridazine—HTR1A—bipolar disorder	0.000179	0.0148	CrCbGaD
Metixene—Promazine—DRD1—bipolar disorder	0.000178	0.0148	CrCbGaD
Metixene—Mianserin—SLC6A4—bipolar disorder	0.000177	0.0147	CrCbGaD
Metixene—Mianserin—DRD2—bipolar disorder	0.000176	0.0146	CrCbGaD
Metixene—CHRM1—brain—bipolar disorder	0.000172	0.0346	CbGeAlD
Metixene—Quetiapine—HTR2C—bipolar disorder	0.000165	0.0137	CrCbGaD
Metixene—Quetiapine—HTR1A—bipolar disorder	0.000161	0.0133	CrCbGaD
Metixene—Mesoridazine—HTR2A—bipolar disorder	0.000155	0.0129	CrCbGaD
Metixene—CHRM3—brain—bipolar disorder	0.000154	0.0309	CbGeAlD
Metixene—Promazine—HTR2C—bipolar disorder	0.000152	0.0126	CrCbGaD
Metixene—Thioridazine—DRD2—bipolar disorder	0.000152	0.0126	CrCbGaD
Metixene—Promethazine—DRD2—bipolar disorder	0.000143	0.0118	CrCbGaD
Metixene—Quetiapine—DRD2—bipolar disorder	0.000136	0.0113	CrCbGaD
Metixene—Mianserin—HTR2A—bipolar disorder	0.000136	0.0113	CrCbGaD
Metixene—Promazine—DRD2—bipolar disorder	0.000125	0.0104	CrCbGaD
Metixene—Thioridazine—HTR2A—bipolar disorder	0.000117	0.00972	CrCbGaD
Metixene—Promethazine—HTR2A—bipolar disorder	0.00011	0.00914	CrCbGaD
Metixene—Quetiapine—HTR2A—bipolar disorder	0.000105	0.00875	CrCbGaD
Metixene—Promazine—HTR2A—bipolar disorder	9.69e-05	0.00804	CrCbGaD
Metixene—HTR2C—Signaling by GPCR—HTR1A—bipolar disorder	5.91e-05	0.00035	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD4—bipolar disorder	5.91e-05	0.00035	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	5.89e-05	0.000349	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—HTR2A—bipolar disorder	5.87e-05	0.000348	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RGS4—bipolar disorder	5.87e-05	0.000347	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—TAC1—bipolar disorder	5.82e-05	0.000344	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—HTR2A—bipolar disorder	5.81e-05	0.000344	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TRPC3—bipolar disorder	5.81e-05	0.000344	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD1—bipolar disorder	5.71e-05	0.000338	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DGKH—bipolar disorder	5.65e-05	0.000334	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DGKH—bipolar disorder	5.63e-05	0.000333	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	5.62e-05	0.000333	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR1A—bipolar disorder	5.6e-05	0.000332	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DGKH—bipolar disorder	5.58e-05	0.00033	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TRPC3—bipolar disorder	5.56e-05	0.000329	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—ADCY2—bipolar disorder	5.56e-05	0.000329	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR1A—bipolar disorder	5.55e-05	0.000328	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADM—bipolar disorder	5.54e-05	0.000328	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	5.53e-05	0.000328	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD3—bipolar disorder	5.53e-05	0.000327	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—TAC1—bipolar disorder	5.52e-05	0.000326	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD2—bipolar disorder	5.5e-05	0.000326	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—TAC1—bipolar disorder	5.46e-05	0.000323	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—POMC—bipolar disorder	5.45e-05	0.000322	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	5.43e-05	0.000321	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	5.43e-05	0.000321	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD1—bipolar disorder	5.41e-05	0.00032	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR2C—bipolar disorder	5.41e-05	0.00032	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TSHB—bipolar disorder	5.4e-05	0.00032	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PDE4B—bipolar disorder	5.4e-05	0.00032	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TACR1—bipolar disorder	5.4e-05	0.00032	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	5.36e-05	0.000317	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR2C—bipolar disorder	5.36e-05	0.000317	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD1—bipolar disorder	5.36e-05	0.000317	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADM—bipolar disorder	5.31e-05	0.000314	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	5.26e-05	0.000311	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD3—bipolar disorder	5.24e-05	0.00031	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD3—bipolar disorder	5.19e-05	0.000307	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TSHB—bipolar disorder	5.17e-05	0.000306	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PDE4B—bipolar disorder	5.17e-05	0.000306	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TACR1—bipolar disorder	5.17e-05	0.000306	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD5—bipolar disorder	5.17e-05	0.000306	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD5—bipolar disorder	5.15e-05	0.000305	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	5.1e-05	0.000302	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	5.1e-05	0.000302	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD5—bipolar disorder	5.1e-05	0.000302	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR1A—bipolar disorder	5.09e-05	0.000301	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD4—bipolar disorder	5.09e-05	0.000301	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RGS4—bipolar disorder	5.07e-05	0.0003	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RGS4—bipolar disorder	5.05e-05	0.000299	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	5.05e-05	0.000299	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR1A—bipolar disorder	5.04e-05	0.000298	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD4—bipolar disorder	5.04e-05	0.000298	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	5.02e-05	0.000297	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—TAC1—bipolar disorder	5.01e-05	0.000296	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RGS4—bipolar disorder	5e-05	0.000296	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	5e-05	0.000296	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—TAC1—bipolar disorder	4.96e-05	0.000294	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HTR2A—bipolar disorder	4.94e-05	0.000292	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	4.93e-05	0.000292	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	4.93e-05	0.000292	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD1—bipolar disorder	4.91e-05	0.000291	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR2C—bipolar disorder	4.91e-05	0.000291	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD1—bipolar disorder	4.86e-05	0.000288	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR2C—bipolar disorder	4.86e-05	0.000288	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	4.8e-05	0.000284	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADCY2—bipolar disorder	4.79e-05	0.000283	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	4.77e-05	0.000282	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD3—bipolar disorder	4.76e-05	0.000282	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	4.75e-05	0.000281	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADCY2—bipolar disorder	4.74e-05	0.000281	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD2—bipolar disorder	4.74e-05	0.00028	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HTR2A—bipolar disorder	4.73e-05	0.00028	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD3—bipolar disorder	4.71e-05	0.000279	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—POMC—bipolar disorder	4.7e-05	0.000278	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD2—bipolar disorder	4.69e-05	0.000278	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—POMC—bipolar disorder	4.69e-05	0.000278	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—POMC—bipolar disorder	4.64e-05	0.000275	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	4.63e-05	0.000274	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD4—bipolar disorder	4.62e-05	0.000273	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD4—bipolar disorder	4.57e-05	0.000271	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	4.53e-05	0.000268	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HTR2A—bipolar disorder	4.48e-05	0.000265	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR1A—bipolar disorder	4.47e-05	0.000265	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CLOCK—bipolar disorder	4.45e-05	0.000264	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TAC1—bipolar disorder	4.4e-05	0.000261	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	4.36e-05	0.000258	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADCY2—bipolar disorder	4.35e-05	0.000257	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TSHB—bipolar disorder	4.34e-05	0.000257	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TPH2—bipolar disorder	4.34e-05	0.000257	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CACNB2—bipolar disorder	4.34e-05	0.000257	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADM—bipolar disorder	4.33e-05	0.000256	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR2C—bipolar disorder	4.32e-05	0.000256	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD1—bipolar disorder	4.32e-05	0.000256	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	4.32e-05	0.000255	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADCY2—bipolar disorder	4.3e-05	0.000255	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD2—bipolar disorder	4.3e-05	0.000255	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HTR2A—bipolar disorder	4.29e-05	0.000254	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR1A—bipolar disorder	4.28e-05	0.000253	CbGpPWpGaD
Metixene—CHRM3—Metabolism—DPYD—bipolar disorder	4.27e-05	0.000253	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD2—bipolar disorder	4.26e-05	0.000252	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	4.22e-05	0.00025	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TAC1—bipolar disorder	4.22e-05	0.00025	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TACR1—bipolar disorder	4.22e-05	0.00025	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TSHB—bipolar disorder	4.22e-05	0.00025	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NTRK2—bipolar disorder	4.2e-05	0.000249	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD3—bipolar disorder	4.18e-05	0.000247	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GSK3A—bipolar disorder	4.16e-05	0.000246	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR2C—bipolar disorder	4.13e-05	0.000245	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD1—bipolar disorder	4.13e-05	0.000245	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD4—bipolar disorder	4.06e-05	0.00024	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NTRK2—bipolar disorder	4.02e-05	0.000238	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD3—bipolar disorder	4e-05	0.000237	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GSK3A—bipolar disorder	3.99e-05	0.000236	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CACNA1C—bipolar disorder	3.97e-05	0.000235	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—POMC—bipolar disorder	3.94e-05	0.000233	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	3.92e-05	0.000232	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TRPC3—bipolar disorder	3.9e-05	0.000231	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD4—bipolar disorder	3.89e-05	0.00023	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3C2A—bipolar disorder	3.87e-05	0.000229	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	3.87e-05	0.000229	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	3.85e-05	0.000228	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADCY2—bipolar disorder	3.82e-05	0.000226	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TCF7L2—bipolar disorder	3.81e-05	0.000225	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD2—bipolar disorder	3.78e-05	0.000224	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—POMC—bipolar disorder	3.78e-05	0.000223	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADM—bipolar disorder	3.74e-05	0.000221	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADM—bipolar disorder	3.72e-05	0.00022	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADM—bipolar disorder	3.69e-05	0.000218	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADCY2—bipolar disorder	3.66e-05	0.000217	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TCF7L2—bipolar disorder	3.65e-05	0.000216	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TSHB—bipolar disorder	3.64e-05	0.000216	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	3.64e-05	0.000216	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TACR1—bipolar disorder	3.64e-05	0.000216	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TSHB—bipolar disorder	3.63e-05	0.000215	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	3.63e-05	0.000215	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TACR1—bipolar disorder	3.63e-05	0.000215	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD2—bipolar disorder	3.62e-05	0.000214	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	3.59e-05	0.000213	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TSHB—bipolar disorder	3.59e-05	0.000213	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TACR1—bipolar disorder	3.59e-05	0.000213	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—POMC—bipolar disorder	3.58e-05	0.000212	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	3.5e-05	0.000207	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	3.49e-05	0.000207	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SNAP25—bipolar disorder	3.47e-05	0.000205	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TAC1—bipolar disorder	3.44e-05	0.000203	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—POMC—bipolar disorder	3.43e-05	0.000203	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NTRK1—bipolar disorder	3.42e-05	0.000203	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD1—bipolar disorder	3.37e-05	0.000199	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	3.33e-05	0.000197	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—S100B—bipolar disorder	3.33e-05	0.000197	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	3.32e-05	0.000196	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	3.29e-05	0.000194	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	3.28e-05	0.000194	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NTRK1—bipolar disorder	3.28e-05	0.000194	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD3—bipolar disorder	3.26e-05	0.000193	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	3.25e-05	0.000192	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—S100B—bipolar disorder	3.19e-05	0.000189	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD4—bipolar disorder	3.17e-05	0.000188	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	3.08e-05	0.000182	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ADCY2—bipolar disorder	3.07e-05	0.000182	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	3.02e-05	0.000179	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	3.01e-05	0.000178	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	3.01e-05	0.000178	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	3e-05	0.000178	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	2.98e-05	0.000177	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	2.98e-05	0.000177	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	2.98e-05	0.000176	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	2.97e-05	0.000176	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TAC1—bipolar disorder	2.97e-05	0.000176	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TAC1—bipolar disorder	2.96e-05	0.000175	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD2—bipolar disorder	2.95e-05	0.000175	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NRG1—bipolar disorder	2.94e-05	0.000174	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TAC1—bipolar disorder	2.93e-05	0.000173	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	2.91e-05	0.000172	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD1—bipolar disorder	2.91e-05	0.000172	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	2.9e-05	0.000172	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD1—bipolar disorder	2.9e-05	0.000172	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	2.87e-05	0.00017	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD1—bipolar disorder	2.87e-05	0.00017	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	2.83e-05	0.000168	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	2.82e-05	0.000167	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD3—bipolar disorder	2.82e-05	0.000167	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NRG1—bipolar disorder	2.81e-05	0.000166	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD3—bipolar disorder	2.81e-05	0.000166	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	2.81e-05	0.000166	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	2.8e-05	0.000166	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	2.8e-05	0.000165	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—POMC—bipolar disorder	2.8e-05	0.000165	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD3—bipolar disorder	2.78e-05	0.000165	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	2.77e-05	0.000164	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD4—bipolar disorder	2.74e-05	0.000162	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD4—bipolar disorder	2.73e-05	0.000161	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD4—bipolar disorder	2.7e-05	0.00016	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	2.67e-05	0.000158	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	2.66e-05	0.000157	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	2.65e-05	0.000157	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	2.65e-05	0.000157	CbGpPWpGaD
Metixene—CHRM3—Metabolism—COMT—bipolar disorder	2.63e-05	0.000156	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	2.62e-05	0.000155	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MAOA—bipolar disorder	2.61e-05	0.000155	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—S100B—bipolar disorder	2.6e-05	0.000154	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	2.58e-05	0.000152	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	2.57e-05	0.000152	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	2.57e-05	0.000152	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	2.56e-05	0.000151	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD2—bipolar disorder	2.55e-05	0.000151	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	2.54e-05	0.000151	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD2—bipolar disorder	2.54e-05	0.00015	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	2.54e-05	0.00015	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	2.53e-05	0.00015	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD2—bipolar disorder	2.52e-05	0.000149	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—POMC—bipolar disorder	2.41e-05	0.000143	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—POMC—bipolar disorder	2.41e-05	0.000142	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—POMC—bipolar disorder	2.38e-05	0.000141	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	2.31e-05	0.000137	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	2.3e-05	0.000136	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NRG1—bipolar disorder	2.29e-05	0.000136	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	2.28e-05	0.000135	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—S100B—bipolar disorder	2.24e-05	0.000133	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—S100B—bipolar disorder	2.24e-05	0.000132	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—S100B—bipolar disorder	2.22e-05	0.000131	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	2.13e-05	0.000126	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MTHFR—bipolar disorder	2.13e-05	0.000126	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—POMC—bipolar disorder	2.12e-05	0.000125	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—INS—bipolar disorder	2.1e-05	0.000124	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	2.07e-05	0.000122	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	2.04e-05	0.000121	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—POMC—bipolar disorder	2.03e-05	0.00012	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—INS—bipolar disorder	2.01e-05	0.000119	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NRG1—bipolar disorder	1.98e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NRG1—bipolar disorder	1.97e-05	0.000117	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NRG1—bipolar disorder	1.96e-05	0.000116	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	1.79e-05	0.000106	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	1.78e-05	0.000105	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	1.76e-05	0.000104	CbGpPWpGaD
Metixene—CHRM3—Metabolism—POMC—bipolar disorder	1.7e-05	0.000101	CbGpPWpGaD
Metixene—CHRM3—Metabolism—INS—bipolar disorder	1.69e-05	0.0001	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	1.66e-05	9.85e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—POMC—bipolar disorder	1.65e-05	9.77e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—INS—bipolar disorder	1.64e-05	9.72e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	1.44e-05	8.51e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	1.43e-05	8.48e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—POMC—bipolar disorder	1.43e-05	8.44e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—POMC—bipolar disorder	1.42e-05	8.41e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	1.42e-05	8.4e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—INS—bipolar disorder	1.42e-05	8.39e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—INS—bipolar disorder	1.41e-05	8.37e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—POMC—bipolar disorder	1.41e-05	8.33e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—INS—bipolar disorder	1.4e-05	8.29e-05	CbGpPWpGaD
